Joke de Boer

1.6k total citations
28 papers, 550 citations indexed

About

Joke de Boer is a scholar working on Ophthalmology, Rheumatology and Dermatology. According to data from OpenAlex, Joke de Boer has authored 28 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 13 papers in Rheumatology and 8 papers in Dermatology. Recurrent topics in Joke de Boer's work include Ocular Diseases and Behçet’s Syndrome (17 papers), Systemic Lupus Erythematosus Research (10 papers) and Dermatology and Skin Diseases (8 papers). Joke de Boer is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (17 papers), Systemic Lupus Erythematosus Research (10 papers) and Dermatology and Skin Diseases (8 papers). Joke de Boer collaborates with scholars based in Netherlands, Germany and United States. Joke de Boer's co-authors include Aniki Rothová, Harold W. de Valk, Jonas J. W. Kuiper, Tos T. J. M. Berendschot, Timothy R. D. J. Radstake, Jordi Antón, Arnd Heiligenhaus, Athimalaipet V Ramanan, Kaisu Kotaniemi and Friederike Mackensen and has published in prestigious journals such as American Journal of Ophthalmology, Progress in Retinal and Eye Research and British Journal of Ophthalmology.

In The Last Decade

Joke de Boer

25 papers receiving 544 citations

Peers

Joke de Boer
Ujwala S. Saboo United States
Akiko Suda Japan
R. Oktay Kaçmaz United States
Cailin H. Sibley United States
Kurtuluş Didem Yazganoğlu Türkiye
Stephen D. Anesi United States
Teresa L. Liesegang United States
Elke O. Kreps Belgium
Nilgün Solak Tekin Türkiye
Filipe Barcelos Portugal
Ujwala S. Saboo United States
Joke de Boer
Citations per year, relative to Joke de Boer Joke de Boer (= 1×) peers Ujwala S. Saboo

Countries citing papers authored by Joke de Boer

Since Specialization
Citations

This map shows the geographic impact of Joke de Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joke de Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joke de Boer more than expected).

Fields of papers citing papers by Joke de Boer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joke de Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joke de Boer. The network helps show where Joke de Boer may publish in the future.

Co-authorship network of co-authors of Joke de Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Joke de Boer. A scholar is included among the top collaborators of Joke de Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joke de Boer. Joke de Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wit, Ferdinand, et al.. (2025). Reference values for the Teller Acuity Cards II (TAC II) in infants and preverbal children, a meta‐analysis. Acta Ophthalmologica. 103(4). 479–485.
3.
Boer, Joke de, et al.. (2025). Paediatric Neoplastic Uveitis Masquerade Syndromes. Ocular Immunology and Inflammation. 34(2). 229–241.
4.
Foeldvari, Ivan, Harry Petrushkin, Regitze Bangsgaard, et al.. (2024). A practical approach to uveitis screening in children with juvenile idiopathic arthritis. British Journal of Ophthalmology. 109(3). 372–376. 3 indexed citations
5.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2024). Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy. Clinical & Experimental Allergy. 54(4). 241–252. 8 indexed citations
6.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2023). High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease. Clinical and Translational Allergy. 13(1). e12221–e12221. 8 indexed citations
7.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2023). Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis. Allergy. 78(8). 2266–2276. 15 indexed citations
8.
Boer, Joke de, et al.. (2022). Clinical Course and Outcome in Pediatric Idiopathic Chronic Anterior Uveitis. American Journal of Ophthalmology. 241. 198–205. 11 indexed citations
9.
Luijk, Chantal van, Daphne S. Bakker, Lotte S. Spekhorst, et al.. (2022). Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis. Acta Dermato Venereologica. 102. adv00666–adv00666. 13 indexed citations
10.
Luijk, Chantal van, Daphne S. Bakker, Lotte S. Spekhorst, et al.. (2022). Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.. PubMed. 102. adv00666–adv00666. 7 indexed citations
11.
Foeldvari, Ivan, Ilaria Maccora, Harry Petrushkin, et al.. (2022). New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis and Idiopathic Chronic Anterior Uveitis. Arthritis Care & Research. 75(5). 975–982. 27 indexed citations
12.
Bakker, Daphne S., Lieneke F.M. Ariëns, Amanda Lans, et al.. (2020). Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis. The Journal of Allergy and Clinical Immunology In Practice. 9(3). 1389–1392.e2. 31 indexed citations
13.
Boer, Joke de, et al.. (2019). Clinical Manifestations, Prognosis, and Vaccination Status of Patients With Rubella Virus–Associated Uveitis. American Journal of Ophthalmology. 202. 37–46. 20 indexed citations
14.
Tappeiner, Christoph, Marina Mesquida, Alfredo Adán, et al.. (2016). Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 43(12). 2183–2188. 80 indexed citations
15.
Kuiper, Jonas J. W., et al.. (2016). Systemic inflammatory immune signatures in a patient with CRB1 linked retinal dystrophy. Expert Review of Clinical Immunology. 12(12). 1359–1362. 18 indexed citations
16.
Kuiper, Jonas J. W., Aniki Rothová, Joke de Boer, & Timothy R. D. J. Radstake. (2014). The immunopathogenesis of birdshot chorioretinopathy; a bird of many feathers. Progress in Retinal and Eye Research. 44. 99–110. 40 indexed citations
17.
Ayuso, Viera Kalinina, et al.. (2013). Ocular Complications in Children Within 1 Year After Hematopoietic Stem Cell Transplantation. JAMA Ophthalmology. 131(4). 470–470. 12 indexed citations
18.
19.
Valk, Harold W. de, et al.. (2008). Human Leukocyte Antigen-B27–Associated Uveitis: Long-term Follow-up and Gender Differences. American Journal of Ophthalmology. 145(3). 472–479. 59 indexed citations
20.
Boer, Joke de, et al.. (2006). Long-term Follow-up of Intermediate Uveitis in Children. American Journal of Ophthalmology. 141(4). 616–616.e7. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ujwala S. Saboo Breakdown of academic impact, for papers by Akiko Suda Breakdown of academic impact, for papers by R. Oktay Kaçmaz Breakdown of academic impact, for papers by Cailin H. Sibley Breakdown of academic impact, for papers by Kurtuluş Didem Yazganoğlu Breakdown of academic impact, for papers by Stephen D. Anesi Breakdown of academic impact, for papers by Teresa L. Liesegang Breakdown of academic impact, for papers by Elke O. Kreps Breakdown of academic impact, for papers by Nilgün Solak Tekin Breakdown of academic impact, for papers by Filipe Barcelos
Rankless by CCL
2026